Differential Effect of Baseline Computed Tomographic Angiography Collaterals on Clinical Outcome in Patients Enrolled in the Interventional Management of Stroke III Trial [Clinical Sciences]
Conclusion—
Using data from a large randomized controlled trial (IMS III), we show that baseline computed tomographic angiography collaterals are a robust determinant of final clinical outcome and could be used to select patients for endovascular therapy.
Clinical Trial Registration—
URL: http://www.clinicaltrials.gov/ct2/show/. Unique identifier: 0020NCT00359424.
Source: Stroke - Category: Neurology Authors: Menon, B. K., Qazi, E., Nambiar, V., Foster, L. D., Yeatts, S. D., Liebeskind, D., Jovin, T. G., Goyal, M., Hill, M. D., Tomsick, T. A., Broderick, J. P., Demchuk, A. M., for the Interventional Management of Stroke III Investigators Tags: Acute Cerebral Infarction, Emergency treatment of Stroke, Computerized tomography and Magnetic Resonance Imaging Clinical Sciences Source Type: research
More News: Angiography | Clinical Trials | Computers | Emergency Medicine | Ischemic Stroke | Men | MRI Scan | Neurology | Statistics | Stroke